Lung Neoplasms

"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the LUNG.

Descriptor ID	D008175
MeSH Number(s)	C04.588.894.797.520 C08.381.540 C08.785.520
Concept/Terms	Lung Neoplasms Lung Neoplasms Pulmonary Neoplasms Neoplasms, Lung Lung Neoplasm Neoplasm, Lung Neoplasms, Pulmonary Neoplasm, Pulmonary Pulmonary Neoplasm Lung Cancer Lung Cancer Cancer, Lung Cancers, Lung Lung Cancers Pulmonary Cancer Cancer, Pulmonary Cancers, Pulmonary Pulmonary Cancers Cancer of the Lung Cancer of Lung

Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Thoracic Neoplasms [C04.588.894]
Respiratory Tract Neoplasms [C04.588.894.797]
Lung Neoplasms [C04.588.894.797.520]
Respiratory Tract Diseases [C08]
Lung Diseases [C08.381]
Lung Neoplasms [C08.381.540]
Respiratory Tract Neoplasms [C08.785]
Lung Neoplasms [C08.785.520]

Below are MeSH descriptors whose meaning is related to "Lung Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.

Bar chart showing 293 publications over 26 distinct years, with a maximum of 23 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	1	2
1998	1	2	3
1999	1	1	2
2002	3	1	4
2003	5	2	7
2004	8	1	9
2005	8	1	9
2006	6	3	9
2007	8	0	8
2008	11	5	16
2009	6	4	10
2010	6	4	10
2011	9	4	13
2012	4	3	7
2013	7	6	13
2014	22	1	23
2015	17	3	20
2016	18	2	20
2017	14	0	14
2018	19	1	20
2019	7	2	9
2020	12	0	12
2021	13	0	13
2022	17	0	17
2023	14	0	14
2024	9	0	9

Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.

Kariya M, Yamamoto K, Kawamura A, Tanizaki S, Ueda K, Sai K, Hata A. Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study. Support Care Cancer. 2024 Jun 03; 32(6):400.

View in: PubMed
Richmond J, Fernandez JR, Bonnet K, Sellers A, Schlundt DG, Forde AT, Wilkins CH, Aldrich MC. Patient Lung Cancer Screening Decisions and Environmental and Psychosocial Factors. JAMA Netw Open. 2024 May 01; 7(5):e2412880.

View in: PubMed
Thompson CA, Sheridan P, Metwally E, Peacock Hinton S, Mullins MA, Dillon EC, Thompson M, Pettit N, Kurian AW, Pruitt SL, Lyratzopoulos G. Emergency department involvement in the diagnosis of cancer among older adults: a SEER-Medicare study. JNCI Cancer Spectr. 2024 Apr 30; 8(3).

View in: PubMed
Yoon HS, Wu J, Shidal C, Sun Y, Franke AA, Yang JJ, Braithwaite D, Courtney R, Cai H, Blot WJ, Shu XO, Zheng W, Cai Q. Associations between Plasma Tocopherols and Lung Cancer Risk: Results from the Southern Community Cohort Study. Cancer Epidemiol Biomarkers Prev. 2024 Apr 03; 33(4):480-488.

View in: PubMed
Harada E, Yoshida S, Imaizumi Y, Kawamura A, Ohtsuka T, Yoshida K. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma. Biochim Biophys Acta Gen Subj. 2024 Jun; 1868(6):130600.

View in: PubMed
Rajasekaran N, Wang X, Ravindranathan S, Chin DJ, Tseng SY, Klakamp SL, Widmann K, Kapoor VN, Vexler V, Keegan P, Yao S, LaVallee T, Khare SD. Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells. Cancer Immunol Immunother. 2024 Feb 24; 73(3):60.

View in: PubMed
Yin X, Kishida R, Abe SK, Islam MR, Rahman MS, Saito E, Lan Q, Blechter B, Merritt M, Choi JY, Shin A, Katagiri R, Shu XO, Sawada N, Tamakoshi A, Koh WP, Tsuji I, Nagata C, Park SK, Kweon SS, Gao YT, Tsugane S, Kimura T, Yuan JM, Lu Y, Kanemura S, Sugawara Y, Wada K, Shin MH, Ahsan H, Boffetta P, Chia KS, Matsuo K, Qiao YL, Rothman N, Zheng W, Inoue M, Kang D, Seow WJ. Association between reproductive factors with lung cancer incidence and mortality: A pooled analysis of over 308,000 females in the Asia cohort consortium. Int J Cancer. 2024 Jun 15; 154(12):2090-2105.

View in: PubMed
Yano Y, Abnet CC, Roshandel G, Graf A, Poustchi H, Khoshnia M, Pourshams A, Kamangar F, Boffetta P, Brennan P, Dawsey SM, Vogtmann E, Malekzadeh R, Etemadi A. Dental health and lung cancer risk in the Golestan Cohort Study. BMC Cancer. 2024 Jan 13; 24(1):74.

View in: PubMed
Madorsky Rowdo FP, Xiao G, Khramtsova GF, Nguyen J, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK, Awuah B, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Gyan KK, Altorki NK, Cheng E, Ginter PS, Hoda S, Newman L, Elemento O, Olopade OI, Davis MB, Martin ML, Bargonetti J. Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment. Cancer Lett. 2024 Mar 01; 584:216608.

View in: PubMed
Kang J, Kim T, Han KD, Jung JH, Jeong SM, Yeo YH, Jung K, Lee H, Cho JH, Shin DW. Risk factors for early-onset lung cancer in Korea: analysis of a nationally representative population-based cohort. Epidemiol Health. 2023; 45:e2023101.

View in: PubMed

People

Explore

Similar Concepts

Top Journals